Catalyst Wire Dossier Catalyst Wire Dossier

SARS-CoV-2 BA.4/5 mRNA vaccine

· Suzhou Abogen Biosciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SARS-CoV-2 BA.4/5 mRNA vaccine, covering 2024-08-07 to 2024-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine [Phase 2, Phase 3]

See pricing